AULT yields 930.67% · JNJ yields 2.14%● Live data
📍 AULT pulled ahead of the other in Year 1
Combined, AULT + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AULT + JNJ for your $10,000?
Ault Alliance, Inc., through its subsidiaries, provides customized solutions for the military markets in North America, Europe, the Middle East, and internationally. The company operates through eight segments: Energy and Infrastructure, Technology and Finance, SMC, BNI, GIGA, TurnOnGreen, AGREE, and Ault Disruptive. It offers lifting services; virtual markets, real world goods marketplaces, gaming, sweepstakes gaming, contest of skill, and building private spaces, as well as social hubs and unique and virtual world. The company also provides consumer electronic solutions; commercial loans, convertible notes, and revolving lines of credit; and virtual training courses through the LightSpeedVT platform, as well as creates various media, communications, and content, including web development, corporate communications, social media, and scripted and unscripted television. In addition, it invests in public and private companies; and various commercial and residential real estate, including hospitality, multifamily, and industrial properties, as well as operates hotels and other commercial real estate, and data centers; and Bitcoin mining activities. It sells its products directly through its sales force, as well as through manufacturer representatives and distributors. It serves crane services, oil exploration, defense/aerospace, industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles industries. The company was formerly known as BitNile Holdings, Inc. and changed its name to Ault Alliance, Inc. in January 2023. Ault Alliance, Inc. was incorporated in 1969 and is headquartered in Las Vegas, Nevada.
Full AULT Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.